Featured patents

Method for Treating Hyperuricemia Employing an SGLT2 Inhibitor and Composition Containing Same
US 08791077 B2, July 29, 2014, Carbohydrate DOAI, Bruce Robert Leslie / AstraZeneca AB (Sodertalje, SE)
A method for treating hyperuricemia in a mammal comprising administering…

Pack of Medicinal Tablets
US 08697718 B2, April 15, 2014, Polycyclo ring system having the six-membered hetero ring as one of the cyclos, Neil Hyde et al. / RB Pharmaceuticals Limited (Slough, Berkshire, GB)
A water- and oxygen-occlusive blister pack enclosing an inert atmosphere storing…

Solid Dispersion of Alpha-Ketoamide Derivatives
US 08697746 B2, April 15, 2014, The ring is a benzene ring, Andrew Xian Chen et al. / Senju Pharmaceutical Co., Ltd. (Osaka-shi, JP)
A solid dispersion comprising…

Arylsulfonamide CCR3 Antagonists
US 08658642 B2, Feb. 25, 2014, Plural ring nitrogens in the additional hetero ring, Jared Andrew Forrester et al. / Axikin Pharmaceuticals, Inc. (San Diego, US)
A method for the treatment or amelioration of one or more symptoms of asthma…

Use of Inhibitors of the Renin-Angiotensin System
US 08604070 B2, Dec. 10, 2013, Tetrazoles (including hydrogenated), John Francis Martin et al. / FinVector Vision Therapies, Ltd. (Oxfordshire, GB)
A method for the treatment of a person, wherein said method comprises…

Inhibitor Compounds and Cancer Treatment Methods
US 08580792 B2, Nov. 12, 2013, Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding, Wayne R. Danter / Critical Outcome Technologies Inc. (London, Ontario, CA)
A therapeutically effective composition for use in the treatment of cancer…

Antimicrobial and Radioprotective Compounds
US 08569363 B2, Oct. 29, 2013, Nitrogen containing, Peter Prokofievich Denisenko et al. / Biodiem Ltd. (Melbourne, Victoria, AU)
A method for the therapeutic treatment of a skin or soft tissue infection wherein…

Methods of Using Selective Chemotherapeutic Agents for Targeting Tumor Cells
US 08552014 B2, Oct. 8, 2013, The other cyclo in the bicyclo ring system is a pyrrole ring (including hydrogenated), Aleem Gangjee et al. / Duquesne University of The Holy Ghost (Pittsburgh, US)
A method for inhibiting GARFTase in cancerous tumors of a patient comprising:…

Non-Immunosuppressive Cyclosporin for Treatment of Ullrich Congenital Muscular Dystrophy
US 08450281 B2, May 28, 2013, Cyclosporine or derivative utilizing, Rafael Crabbe et al. / Debiopharm S.A. (Lausanne, CH)
A method for treatment of Ullrich congenital muscular dystrophy or Bethlem…

Soluble Epoxide Hydrolase Inhibitors, Compositions Containing Such Compounds and Methods of Treatment
US 08455520 B2, June 4, 2013, C=X bonded directly to the piperidine ring (X is chalcogen), Fa-Xiang Ding et al. / Merck Sharp & Dohme Corp. (Rahway, US)
A compound represented by formula I:…

Patentorg has 8391 documents under Drugs: Designated Organic Active Ingredient Containing Patents.

Narrow down the browsing criteria below to see more patents.

Select a subcategory
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot